Mauna Kea Technologies' Cellvizio technology has received a CE mark for use in minimally invasive laparoscopic surgical indications.
Cellvizio is designed to provide real-time visualization of tissue at the microscopic level. Through the expanded indication in Europe, Cellvizio could now be used in a wide range of oncologic surgical procedures.